The U.S. Food and Drug Administration approved the Keytruda combination in malignant pleural mesothelioma in September. Keytruda, a cancer drug that harnesses a patient's immune system to fight tumors ...
However, vascular endothelial growth factor (VEGF), a potent angiogenic mediator and promoter of endothelial permeability, is produced in significant amounts by diseased pleural tissue and is thought ...
The investigators used ICD-10 codes to identify patients in the database whose first hospital event met these criteria: (1) a diagnosis of liver cirrhosis; (2) inpatient pleural fluid cell counts ...